Anaemia Clinical Trial
Official title:
Hand Hygiene Promotion Activities: Effect on Intestinal Parasitic Infections and Anaemia Among School-aged Children in Eastern Tigray, Ethiopia: a Factorial Randomised Controlled Trial
Verified date | January 2015 |
Source | Mekelle University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Ethiopia: Ethical Review Committee |
Study type | Interventional |
Impact exerted by intestinal parasitic infections is much higher in developing countries.
School-aged children are at higher risk from the burden of disease, because they specially
have many parasitic infections. The poor health results in deficits in physical and
cognitive development and educational achievements. Nowadays, there is huge commitment among
the global community to control intestinal parasitic infections and to improve nutritional
status of young children in developing countries.
Large-scale anthelminthic drug administration through vertical control programmes is still
required for the foreseeable future and is, therefore, recommended by the World Health
Organization (WHO). However, due to the inevitability of re-infection in endemic areas,
children need to be treated regularly, and once morbidity control is consolidated, the
strategy must shift to transmission control emphasising access to clean water and adequate
sanitation. To lower dependency on 'drug only' approach and to enhance sustainability, from
the onset of control activities, complementary measures should be implemented, that depend
on available resources.
Therefore, the investigators are proposing to undertake a randomised controlled trial to
assess the impact of simple and easy-to-do hand hygiene intervention packages (hand washing
with soap and hand finger nail clipping) on intestinal parasitic infection prevalence,
intensity and re-infection rates and on haemoglobin concentration and anaemia prevalence
rates among 6-15 years old schoolchildren. Our results will provide solid evidence on if and
how hand hygiene practice affects infection prevalence and re-infection rates, as well as,
anaemia prevalence among the highly vulnerable age group.
Status | Completed |
Enrollment | 365 |
Est. completion date | February 2013 |
Est. primary completion date | February 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 6 Years to 15 Years |
Eligibility |
Inclusion Criteria: - households and children who will give a written consent to participate in the study - households and children who are going to stay in the area throughout the study period - children aged 6 to 15 Exclusion Criteria: - households and children who able to produce a written consent - children who are under treatment - children with age less than 6 and greater than 15 years |
Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Ethiopia | College of Health Sciences, Mekelle University | Mekelle | Tigray |
Lead Sponsor | Collaborator |
---|---|
Mekelle University | Maastricht University, University of Alcala |
Ethiopia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | - Proportion of intestinal parasitic re-infection rates among intervention and control groups | Impact of hand hygiene activities (as intervention measures) on intestinal parasitic re-infection prevalence will be assessed. | six months | No |
Primary | - Proportion of intestinal parasite load (mean eggs per gram) among intervention and control groups | Impact of hand hygiene activities (as intervention measures) on intestinal parasitic infection intensity will be assessed. | six months | No |
Secondary | Proportion of anaemia prevalence rates among intervention and control groups | Impact of hand hygiene activities on the reduction of anaemia prevalence among the children will be assessed | six months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05682326 -
Anemia Studies in CKD: Erythropoiesis Via a Novel PHI Daprodustat - Pediatric (ASCEND-P)
|
Phase 3 | |
Completed |
NCT03400033 -
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD)
|
Phase 3 | |
Completed |
NCT02879305 -
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)
|
Phase 3 | |
Completed |
NCT02876835 -
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
|
Phase 3 | |
Terminated |
NCT02801162 -
Evaluation of Accuracy and Precision of a New Arterial Blood Gas Analysis System Blood in Comparison With the Reference Standard
|
N/A | |
Completed |
NCT02288637 -
Evaluation of a Novel Long Lasting Insecticidal Net and Indoor Residual Spray Product
|
N/A | |
Completed |
NCT00276224 -
Iron Supplementation in Schistosomiasis and Soil Transmitted Helminths Control Programmes in Zambia
|
N/A | |
Completed |
NCT00857077 -
Intermittent Preventive Treatment for Malaria in Infants in Navrongo Ghana
|
N/A | |
Completed |
NCT06080555 -
Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia
|
Phase 1 | |
Completed |
NCT01977573 -
A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)
|
Phase 2 | |
Completed |
NCT02243306 -
Study to Assess the Pharmacokinetics of GSK1278863 in Subjects With End Stage Renal Disease Undergoing Peritoneal Dialysis
|
Phase 1 | |
Completed |
NCT01111630 -
Study of Erythropoietin (EPO) Administration Schedule
|
Phase 4 | |
Completed |
NCT00140517 -
Relationships Between the Use of Antimalarial Drugs in Pregnancy and Plasmodium Falciparum Resistance
|
N/A | |
Completed |
NCT03239522 -
Absorption and Elimination of Radiolabeled Daprodustat
|
Phase 1 | |
Completed |
NCT01376232 -
Study to Assess the Pharmacokinetics of GSK1278863A Coadministered With a High Fat Meal or an Inhibitor of CYP2C8 (Gemfibrozil)
|
Phase 1 | |
Completed |
NCT02019719 -
Study to Evaluate the Safety, Efficacy and Pharmacokinetics of GSK1278863 in Japanese Hemodialysis-Dependent Subjects With Anemia Associated With Chronic Kidney Disease
|
Phase 2 | |
Completed |
NCT02969655 -
A Study to Evaluate Efficacy and Safety of Daprodustat Compared to Darbepoetin Alfa in Japanese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT02637102 -
The UK CAVIAR Study
|
||
Completed |
NCT01454752 -
Intermittent Parasite Clearance (IPC) in Schools: Impact on Malaria, Anaemia and Cognition
|
N/A | |
Completed |
NCT01136850 -
Intermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New Guinea
|
Phase 3 |